In the hunt for new therapeutics for cancer and infectious diseases, lasso peptides prove to be a catch. Their knot-like ...

Viltrox has announced a new standard prime with a fast F1.4 aperture for Sony E and Nikon Z mount full-frame cameras.

Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.

Apple is positioning this as the top tablet to buy if you're looking to use AI tools like image-generation apps.

Since its debut in the US in March 2025, Letybo has been positioned as Botox’s biggest competitor in the injection space. And ...